financetom
Business
financetom
/
Business
/
UK to probe Paramount-Warner Bros deal in coming weeks, competition watchdog says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
UK to probe Paramount-Warner Bros deal in coming weeks, competition watchdog says
Apr 13, 2026 6:42 AM

April 13 (Reuters) - Britain's antitrust watchdog is expected to launch an investigation into Paramount Skydance's ( PSKY ) planned $110 billion acquisition of Warner Bros Discovery ( WBD ) in "the coming weeks," a spokesperson said on Monday.

"The film and TV industries contribute billions to our economy, so it's important we assess whether deals between studios may harm competition ... We expect to launch our phase 1 investigation in the coming weeks," a Competition and Markets Authority (CMA) spokesperson said in an emailed statement to Reuters.

The CMA had earlier sought views on the deal's competitive compliance, a standard step in its information-gathering process before it decides on whether to formally launch an investigation into a deal. 

The regulator has given interested parties until April 27 to comment.

Paramount and Warner Bros did not immediately respond to Reuters' request for comments.

Separately, more than 1,000 writers, actors and directors released an open letter on Monday opposing the deal, saying it would harm Hollywood's already distressed entertainment industry. Among those who signed the letter are actors Jane Fonda, Mark Ruffalo and Ben Stiller.

The Paramount-Warner Bros deal was announced in February nL6N3ZN196 following a weeks-long bidding war with Netflix. 

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: KKR-Backed OHB and KNDS Mull Changes to Share Sale Timeline Amid SpaceX IPO
Market Chatter: KKR-Backed OHB and KNDS Mull Changes to Share Sale Timeline Amid SpaceX IPO
May 22, 2026
07:45 AM EDT, 05/22/2026 (MT Newswires) -- KKR-backed (KKR) space company OHB and weapons manufacturer KNDS are considering moving their planned share sales to avoid a clash with SpaceX's (SPCX) initial public offering in the United States, Bloomberg reported Friday, citing people familiar with the matter. Both OHB and KNDS had plans to commence their offerings on June 12, the...
Assembly Biosciences Prices $100 Million Offering
Assembly Biosciences Prices $100 Million Offering
May 22, 2026
07:40 AM EDT, 05/22/2026 (MT Newswires) -- Assembly Biosciences ( ASMB ) said Friday it has priced an underwritten, registered offering of 3,358,602 shares at $26.50 per share and pre-funded warrants to purchase up to 415,000 shares at $26.499 per warrant, for gross proceeds of approximately $100 million. Certain investors will buy the pre-funded warrants in lieu of common stock,...
Top Premarket Decliners
Top Premarket Decliners
May 22, 2026
07:42 AM EDT, 05/22/2026 (MT Newswires) -- Futu ( FUTU ) and UP Fintech ( TIGR ) shares were down 38% and 37%, respectively, in Friday premarket activity after China's securities regulator said the companies could face penalties for operating in mainland China without licenses. NervGen Pharma ( NGEN ) stock was 33% lower after the company priced an offering...
Regeneron Says Otarmeni Application Accepted Under EU Accelerated Assessment
Regeneron Says Otarmeni Application Accepted Under EU Accelerated Assessment
May 22, 2026
07:38 AM EDT, 05/22/2026 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) said Friday the European Medicines Agency has accepted for accelerated assessment its marketing authorization application for Otarmeni to treat OTOF-related hearing loss. The gene therapy, previously known as DB-OTO, targets biallelic OTOF variant-associated hearing loss, the company said. The therapy received accelerated approval in the US in April,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved